Blandt patienter, som gennemførte undersøgelsens 24 måneders behandling, var ikke- progressionsraterne henholdsvis 78%, 70% og 62%.
Among patients who completed a full 24 months of therapy in the study, the non-progression rates were 78%, 70%, and 61%, respectively.